Agios Pharmaceuticals Inc (NAS:AGIO)
$ 60.48 1.42 (2.4%) Market Cap: 3.45 Bil Enterprise Value: 2.42 Bil PE Ratio: 5.32 PB Ratio: 2.12 GF Score: 37/100

Agios Pharmaceuticals Inc at Cowen Healthcare Conference (Virtual) Transcript

Mar 01, 2021 / 04:40PM GMT
Release Date Price: $47.51 (+0.15%)
Marc Alan Frahm
Cowen and Company, LLC, Research Division - Director

Hello, welcome back to the Cowen Healthcare Conference. Thanks, everyone online, for joining. We're -- this session, we're very thrilled to be joined by the management team from Agios in Jackie Fouse, the CEO, as well as Chris Bowden, CMO. And before we hand it over to Jackie to give a brief overview, I just want to remind everyone that you can submit questions. (Operator Instructions)

And with that, Jackie, maybe you want to start off with just a couple minute brief overview, status update of the -- of where Agios is, and then we can get into some of the specific questions.

Jacqualyn A. Fouse
Agios Pharmaceuticals, Inc. - CEO & Director

Yes, great. Thanks so much for having us on the -- part of the conference this morning. So we're happy to be here. So you may have paid attention to our results call last week, and we've certainly had a lot going on at Agios, particularly since the announcement that we made on December 21 related to our strategic pivot and focus now in the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot